cbdMD, Inc. — Form 8-K

cbdMD, Inc. (market cap ~$2.8M) entered a definitive asset purchase agreement on September 1, 2026, to acquire substantially all operating assets and brands of Twinlab Consolidated Holdings, Inc. through an assignment-for-benefit-of-creditors proceeding. Purchase price: $3,979,805 consisting of (a) assumption of $1.75M secured debt to Akretive Holdings at 9% annually, (b) issuance of 2,229,805 common shares (~19.9% of outstanding) valued at $1.00/share = $2,229,805, and (c) assumption of specified liabilities. The acquired brands include Twinlab, Reserveage, Metabolife, and Alvita Tea; combined trailing-twelve-month revenue (unaudited, through June 2026) approximately $30M, representing ~40% revenue increase for cbdMD. Transaction is subject to ABC court approval and customary closing conditions.